Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating activities:
Net loss	$ (4,838,205)	$ (3,224,486)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	3,956,384	2,163,530
Provision for doubtful accounts	46,967	25,520
Loss on write-off of notes receivable	0	100,745
Deferred compensation	0	318,975
Stock based compensation	386,864	726,711
Change in operating assets and liabilities:
Restricted cash	(352)	137,119
Accounts receivable	1,959,018	1,227,703
Prepaid expenses and other current assets	23,138	90,657
Accounts payable	1,396,921	(996,225)
Deferred revenue	(13,392)	(1,838)
Other accrued expenses and current liabilities	(3,085,248)	(194,077)
Net cash (used in) provided by operating activities from continuing operations	(167,905)	374,334
Net cash used in operating activities from discontinued operations	(135,000)	(296,424)
Net cash (used in) provided by operating activities	(302,905)	77,910
Investing activities:
Purchases of equipment and capitalized development costs	(628,600)	(245,382)
Net cash received from merger with Vertro, Inc., net of merger costs	2,424,383	0
Purchase of names database and bundled downloads	(2,184,076)	(1,543,247)
Net cash used in investing activities	(388,293)	(1,788,629)
Financing activities:
Proceeds from sale of common stock, net	0	2,680,036
Proceeds from term note	5,000,000	0
Deposit to collateralize letter of credit	(475,000)	0
Advances from credit note payable	3,000,000	4,396,744
Payments on term note payable and capital leases	(3,550,658)	(3,569,625)
Net cash provided by (used in) financing activities	3,974,342	3,507,155
Accumulated other comprehensive income	(5,579)	0
Net change - cash	3,283,144	1,796,436
Cash, beginning of year	4,413	118,561
Cash, end of year	3,281,978	1,914,997
Supplemental information:
Interest paid	238,501	271,506
Non-cash investing activities:
Issuance of stock as settlement of deferred compensation	915,750	0
Restricted advances on term note payable	475,000	475,000
Payment on litigation settlements with common stock	$ 0	$ 365,400